Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · IEX Real-Time Price · USD
26.55
+0.38 (1.45%)
Apr 26, 2024, 4:00 PM EDT - Market closed

ARCT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Net Income
-29.739.35-203.67-72.15-25.99-21.79-10.9-1.57-1.9-32.83
Upgrade
Depreciation & Amortization
2.961.531.190.880.680.580.410.290.190.03
Upgrade
Share-Based Compensation
34.6530.6128.926.761.981.262.170.30.14.09
Upgrade
Other Operating Activities
-25.98-9.4938.5221.6416.88-0.827.86-1.889.90.39
Upgrade
Operating Cash Flow
-18.131.99-135.04-42.86-6.45-20.76-0.46-2.868.29-28.33
Upgrade
Capital Expenditures
-2.9-7.73-3.41-1.74-0.82-1.48-0.22-0.69-0.22-0.08
Upgrade
Change in Investments
0000023.6110.58008.49
Upgrade
Investing Cash Flow
-2.9-7.73-3.41-1.74-0.8222.1310.36-0.69-0.228.41
Upgrade
Share Issuance / Repurchase
3.282.141.42436.1536.960.331.3500.020
Upgrade
Debt Issued / Paid
-27.36-546.604.959.875.6501.890
Upgrade
Financing Cash Flow
-24.09-2.8648.02436.1541.9110.2701.90
Upgrade
Net Cash Flow
-45.0921.41-90.43391.5434.6411.5816.89-3.559.97-19.92
Upgrade
Free Cash Flow
-2124.27-138.45-44.6-7.26-22.24-0.68-3.558.07-28.41
Upgrade
Free Cash Flow Margin
-12.59%11.78%-1120.23%-467.59%-34.94%-141.17%-5.25%-17.41%131.48%-
Upgrade
Free Cash Flow Per Share
-0.790.92-5.26-2.20-0.60-2.21-0.22-1.754.00-14.54
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).